Skip to main content

Bio-Techne RNAscope HiPlex Assay

Bio-Techne released its multiplex in situ hybridization RNAscope HiPlex Assay for tissues. It enables researchers to gain insights into cellular mechanisms and functions by combining a simplistic workflow with the capability of simultaneously detecting up to twelve RNA targets, the firm said.

The research-use-only assay is an expansion of the Advanced Cell Diagnostics RNAscope platform, an advanced in situ hybridization system that enables visualization of single-molecule gene expression with single-cell resolution directly in intact tissues.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.